Management of Diabetic Peripheral Neuropathy / 대한내과학회지
Korean Journal of Medicine
;
: 277-281, 2015.
Article
Dans Coréen
| WPRIM
| ID: wpr-52504
ABSTRACT
Diabetic peripheral neuropathy (DPN) is a common complication of diabetes mellitus. The prevalence of neuropathic pain is estimated to occur in about 30-50% of all diabetic patients. Clinical symptoms vary depending on the nerves affected, and may include both positive and negative symptoms. Many patients with DPN experience pain or discomfort, anxiety, depression, and limitations in activity, which can significantly impact their physical, emotional, and social well-being. Early diagnosis is essential for the successful management of DPN. Routine management consists of glucose and risk factor control, and symptomatic relief, along with therapies designed to target the underlying disease pathology. Pharmacological treatment of DPN includes tricyclic compounds, serotonin noradrenalin reuptake inhibitors, the antioxidant alpha-lipoic acid, anticonvulsants, opiates, membrane stabilizers, topical capsaicin, and other drugs. Management of DPN must be tailored to each individual, and depends on a variety of factors, including disease severity and response to treatment.
Texte intégral:
Disponible
Indice:
WPRIM (Pacifique occidental)
Sujet Principal:
Anxiété
/
Anatomopathologie
/
Capsaïcine
/
Sérotonine
/
Prévalence
/
Facteurs de risque
/
Acide lipoïque
/
Neuropathies périphériques
/
Diagnostic précoce
/
Dépression
Type d'étude:
Etude diagnostique
/
Etude d'étiologie
/
Étude de prévalence
/
Facteurs de risque
/
Étude de dépistage
Limites du sujet:
Humains
langue:
Coréen
Texte intégral:
Korean Journal of Medicine
Année:
2015
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS